Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Automatic Data Processing Inc (ADP) vs BridgeBio Pharma Inc (BBIO) Price & Performance

Automatic Data Processing IncTrade
BridgeBio Pharma IncTrade

Price performance (Past 24H)

Key statistics

Automatic Data Processing Inc vs BridgeBio Pharma Inc — how do they compare? Automatic Data Processing Inc trades at $270.3 (market cap $107.69B), while BridgeBio Pharma Inc trades at $83.9 (market cap $16.36B). The key difference: Automatic Data Processing Inc is far larger — about 6.6× BridgeBio Pharma Inc's market cap, and Automatic Data Processing Inc pays a 2.51% dividend while BridgeBio Pharma Inc pays none. Which is the better fit depends on your goals.

ADPBBIO
Market Cap
$107.69B$16.36B
Sector
IndustrialsHealth
52-Week High
$309.03$90.17
52-Week Low
$188.79$47.29
Enterprise Value
$108.73B$18.14B
Dividend Yield
2.51%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Automatic Data Processing Inc

ADP is a provider of payroll and human capital management solutions servicing the full scope of businesses from micro to global enterprises. ADP was established in 1949 and serves over 990,000 clients primarily in the United States. ADP's employer services segment offers payroll, HCM solutions, HR outsourcing, insurance and retirement services. The smaller but faster-growing PEO segment provides HR outsourcing solutions to small and midsize businesses through a co-employment model.

Read more on ADP

About BridgeBio Pharma Inc

BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.

Read more on BBIO